ReviewBiomedicines2017

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease.

Robert Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.